Support By : Li-lab
PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
---|---|---|---|---|---|
Cardiac muscle contraction | R-HSA-397014 | map04260 | rifabutin | 3585 | drug-path |
Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | rifabutin | 3585 | drug-path |
Colorectal cancer | R-HSA-4791275 | map05210 | rifabutin | 3585 | drug-path |
Hematopoietic cell lineage | R-HSA-173752 | map04640 | rifabutin | 3585 | drug-path |
Taste transduction | R-HSA-162582 | map04742 | rifabutin | 3585 | drug-path |
Autoimmune thyroid disease | R-HSA-1643685 | map05320 | rifabutin | 3585 | drug-path |
Antigen processing and presentation | R-HSA-1236975 | map04612 | rifabutin | 3585 | drug-path |
Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | rifabutin | 3585 | drug-path |
Base excision repair | R-HSA-73884 | map03410 | rifabutin | 3585 | drug-path |
Vibrio cholerae infection | R-HSA-9609646 | map05110 | rifabutin | 3585 | drug-path |
Parkinson's disease | R-HSA-1643685 | 0 | rifabutin | 3585 | drug-path |
Ribosome | R-HSA-5368277 | map03010 | rifabutin | 3585 | drug-path |
Chronic myeloid leukemia | R-HSA-9680350 | map05220 | rifabutin | 3585 | drug-path |
Complement and coagulation cascades | R-HSA-114591 | map04610 | rifabutin | 3585 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | nialamide | 4472 | drug-path |
Systemic lupus erythematosus | R-HSA-977105 | map05322 | nialamide | 4472 | drug-path |
Axon guidance | R-HSA-422475 | map04360 | nialamide | 4472 | drug-path |
Olfactory transduction | R-HSA-9751605 | map04740 | levcycloserine | 449215 | drug-path |
ECM-receptor interaction | R-HSA-373711 | map04512 | levcycloserine | 449215 | drug-path |
Graft-versus-host disease | R-HSA-1643685 | map05332 | levcycloserine | 449215 | drug-path |